世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場予測2023-2029：DTwP型、DTaP型

【英語タイトル】Diphtheria Tetanus Pertussis Vaccine Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8469
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：77
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場規模と予測を収録しています。・世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「DTwP型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル主要企業は、Sanofi Pasteur、 GSK、 AJ Vaccines、 KM Biologics (Meiji)、 MCM Vaccine、 Merck、 MassBiologics、 Bionet-Asia、 Amson Vaccines & Pharma、 Serum Institute of India、 Panacea Biotec、 BioKangtai、 China National Biotec、 Chengdu Oulin Biological Science&Technologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ジフテリア/破傷風/百日咳（DPT）ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場：タイプ別市場シェア、2022年
・DTwP型、DTaP型

世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場：用途別市場シェア、2022年
・子供、青少年、成人

世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル売上、2018年-2023年
・主要企業におけるジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル売上シェア、2022年
・主要企業におけるジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル販売量、2018年-2023年
・主要企業におけるジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Sanofi Pasteur、 GSK、 AJ Vaccines、 KM Biologics (Meiji)、 MCM Vaccine、 Merck、 MassBiologics、 Bionet-Asia、 Amson Vaccines & Pharma、 Serum Institute of India、 Panacea Biotec、 BioKangtai、 China National Biotec、 Chengdu Oulin Biological Science&Technology

*************************************************************

・調査・分析レポートの概要
ジフテリア/破傷風/百日咳（DPT）ワクチン市場の定義
市場セグメント
世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場規模
世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場規模：2022年 VS 2029年
世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのジフテリア/破傷風/百日咳（DPT）ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のジフテリア/破傷風/百日咳（DPT）ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：DTwP型、DTaP型
ジフテリア/破傷風/百日咳（DPT）ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：子供、青少年、成人
ジフテリア/破傷風/百日咳（DPT）ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別ジフテリア/破傷風/百日咳（DPT）ワクチン市場規模 2022年と2029年
地域別ジフテリア/破傷風/百日咳（DPT）ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi Pasteur、 GSK、 AJ Vaccines、 KM Biologics (Meiji)、 MCM Vaccine、 Merck、 MassBiologics、 Bionet-Asia、 Amson Vaccines & Pharma、 Serum Institute of India、 Panacea Biotec、 BioKangtai、 China National Biotec、 Chengdu Oulin Biological Science&Technology
...

The DPT vaccine or DTP vaccine is a class of combination vaccines against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.The vaccine components include diphtheria and tetanus toxoids and either killed whole cells of the bacterium that causes pertussis or pertussis antigens.
This report aims to provide a comprehensive presentation of the global market for Diphtheria Tetanus Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diphtheria Tetanus Pertussis Vaccine. This report contains market size and forecasts of Diphtheria Tetanus Pertussis Vaccine in global, including the following market information:
Global Diphtheria Tetanus Pertussis Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Diphtheria Tetanus Pertussis Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Diphtheria Tetanus Pertussis Vaccine companies in 2022 (%)
The global Diphtheria Tetanus Pertussis Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
DTwP Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diphtheria Tetanus Pertussis Vaccine include Sanofi Pasteur, GSK, AJ Vaccines, KM Biologics (Meiji), MCM Vaccine, Merck, MassBiologics, Bionet-Asia and Amson Vaccines & Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diphtheria Tetanus Pertussis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diphtheria Tetanus Pertussis Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Diphtheria Tetanus Pertussis Vaccine Market Segment Percentages, by Type, 2022 (%)
DTwP Type
DTaP Type
Global Diphtheria Tetanus Pertussis Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Diphtheria Tetanus Pertussis Vaccine Market Segment Percentages, by Application, 2022 (%)
Child
Teenager
Aldult
Global Diphtheria Tetanus Pertussis Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Diphtheria Tetanus Pertussis Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diphtheria Tetanus Pertussis Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Diphtheria Tetanus Pertussis Vaccine revenues share in global market, 2022 (%)
Key companies Diphtheria Tetanus Pertussis Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Diphtheria Tetanus Pertussis Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur
GSK
AJ Vaccines
KM Biologics (Meiji)
MCM Vaccine
Merck
MassBiologics
Bionet-Asia
Amson Vaccines & Pharma
Serum Institute of India
Panacea Biotec
BioKangtai
China National Biotec
Chengdu Oulin Biological Science&Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diphtheria Tetanus Pertussis Vaccine, market overview.
Chapter 2: Global Diphtheria Tetanus Pertussis Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Diphtheria Tetanus Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diphtheria Tetanus Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Diphtheria Tetanus Pertussis Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Diphtheria Tetanus Pertussis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diphtheria Tetanus Pertussis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diphtheria Tetanus Pertussis Vaccine Overall Market Size
2.1 Global Diphtheria Tetanus Pertussis Vaccine Market Size: 2022 VS 2029
2.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Diphtheria Tetanus Pertussis Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Diphtheria Tetanus Pertussis Vaccine Players in Global Market
3.2 Top Global Diphtheria Tetanus Pertussis Vaccine Companies Ranked by Revenue
3.3 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Companies
3.4 Global Diphtheria Tetanus Pertussis Vaccine Sales by Companies
3.5 Global Diphtheria Tetanus Pertussis Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Diphtheria Tetanus Pertussis Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Diphtheria Tetanus Pertussis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diphtheria Tetanus Pertussis Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Diphtheria Tetanus Pertussis Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Diphtheria Tetanus Pertussis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Diphtheria Tetanus Pertussis Vaccine Market Size Markets, 2022 & 2029
4.1.2 DTwP Type
4.1.3 DTaP Type
4.2 By Type – Global Diphtheria Tetanus Pertussis Vaccine Revenue & Forecasts
4.2.1 By Type – Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Diphtheria Tetanus Pertussis Vaccine Sales & Forecasts
4.3.1 By Type – Global Diphtheria Tetanus Pertussis Vaccine Sales, 2018-2023
4.3.2 By Type – Global Diphtheria Tetanus Pertussis Vaccine Sales, 2024-2029
4.3.3 By Type – Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Diphtheria Tetanus Pertussis Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Diphtheria Tetanus Pertussis Vaccine Market Size, 2022 & 2029
5.1.2 Child
5.1.3 Teenager
5.1.4 Aldult
5.2 By Application – Global Diphtheria Tetanus Pertussis Vaccine Revenue & Forecasts
5.2.1 By Application – Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Diphtheria Tetanus Pertussis Vaccine Sales & Forecasts
5.3.1 By Application – Global Diphtheria Tetanus Pertussis Vaccine Sales, 2018-2023
5.3.2 By Application – Global Diphtheria Tetanus Pertussis Vaccine Sales, 2024-2029
5.3.3 By Application – Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Diphtheria Tetanus Pertussis Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Diphtheria Tetanus Pertussis Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Diphtheria Tetanus Pertussis Vaccine Revenue & Forecasts
6.2.1 By Region – Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Diphtheria Tetanus Pertussis Vaccine Sales & Forecasts
6.3.1 By Region – Global Diphtheria Tetanus Pertussis Vaccine Sales, 2018-2023
6.3.2 By Region – Global Diphtheria Tetanus Pertussis Vaccine Sales, 2024-2029
6.3.3 By Region – Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Diphtheria Tetanus Pertussis Vaccine Sales, 2018-2029
6.4.3 US Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.4.4 Canada Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.4.5 Mexico Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Diphtheria Tetanus Pertussis Vaccine Sales, 2018-2029
6.5.3 Germany Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.5.4 France Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.5.5 U.K. Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.5.6 Italy Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.5.7 Russia Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.5.9 Benelux Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Diphtheria Tetanus Pertussis Vaccine Sales, 2018-2029
6.6.3 China Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.6.4 Japan Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.6.5 South Korea Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.6.7 India Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Diphtheria Tetanus Pertussis Vaccine Sales, 2018-2029
6.7.3 Brazil Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.7.4 Argentina Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales, 2018-2029
6.8.3 Turkey Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.8.4 Israel Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
6.8.6 UAE Diphtheria Tetanus Pertussis Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Company Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.1.4 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Pasteur Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.2.4 GSK Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 AJ Vaccines
7.3.1 AJ Vaccines Company Summary
7.3.2 AJ Vaccines Business Overview
7.3.3 AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.3.4 AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 AJ Vaccines Key News & Latest Developments
7.4 KM Biologics (Meiji)
7.4.1 KM Biologics (Meiji) Company Summary
7.4.2 KM Biologics (Meiji) Business Overview
7.4.3 KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.4.4 KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 KM Biologics (Meiji) Key News & Latest Developments
7.5 MCM Vaccine
7.5.1 MCM Vaccine Company Summary
7.5.2 MCM Vaccine Business Overview
7.5.3 MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.5.4 MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 MCM Vaccine Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.6.4 Merck Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 MassBiologics
7.7.1 MassBiologics Company Summary
7.7.2 MassBiologics Business Overview
7.7.3 MassBiologics Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.7.4 MassBiologics Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 MassBiologics Key News & Latest Developments
7.8 Bionet-Asia
7.8.1 Bionet-Asia Company Summary
7.8.2 Bionet-Asia Business Overview
7.8.3 Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.8.4 Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Bionet-Asia Key News & Latest Developments
7.9 Amson Vaccines & Pharma
7.9.1 Amson Vaccines & Pharma Company Summary
7.9.2 Amson Vaccines & Pharma Business Overview
7.9.3 Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.9.4 Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Amson Vaccines & Pharma Key News & Latest Developments
7.10 Serum Institute of India
7.10.1 Serum Institute of India Company Summary
7.10.2 Serum Institute of India Business Overview
7.10.3 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.10.4 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Serum Institute of India Key News & Latest Developments
7.11 Panacea Biotec
7.11.1 Panacea Biotec Company Summary
7.11.2 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Business Overview
7.11.3 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.11.4 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Panacea Biotec Key News & Latest Developments
7.12 BioKangtai
7.12.1 BioKangtai Company Summary
7.12.2 BioKangtai Diphtheria Tetanus Pertussis Vaccine Business Overview
7.12.3 BioKangtai Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.12.4 BioKangtai Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 BioKangtai Key News & Latest Developments
7.13 China National Biotec
7.13.1 China National Biotec Company Summary
7.13.2 China National Biotec Diphtheria Tetanus Pertussis Vaccine Business Overview
7.13.3 China National Biotec Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.13.4 China National Biotec Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 China National Biotec Key News & Latest Developments
7.14 Chengdu Oulin Biological Science&Technology
7.14.1 Chengdu Oulin Biological Science&Technology Company Summary
7.14.2 Chengdu Oulin Biological Science&Technology Business Overview
7.14.3 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Major Product Offerings
7.14.4 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Chengdu Oulin Biological Science&Technology Key News & Latest Developments
8 Global Diphtheria Tetanus Pertussis Vaccine Production Capacity, Analysis
8.1 Global Diphtheria Tetanus Pertussis Vaccine Production Capacity, 2018-2029
8.2 Diphtheria Tetanus Pertussis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Diphtheria Tetanus Pertussis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Diphtheria Tetanus Pertussis Vaccine Supply Chain Analysis
10.1 Diphtheria Tetanus Pertussis Vaccine Industry Value Chain
10.2 Diphtheria Tetanus Pertussis Vaccine Upstream Market
10.3 Diphtheria Tetanus Pertussis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diphtheria Tetanus Pertussis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Diphtheria Tetanus Pertussis Vaccine in Global Market
Table 2. Top Diphtheria Tetanus Pertussis Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Diphtheria Tetanus Pertussis Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Diphtheria Tetanus Pertussis Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Diphtheria Tetanus Pertussis Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Diphtheria Tetanus Pertussis Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Diphtheria Tetanus Pertussis Vaccine Product Type
Table 9. List of Global Tier 1 Diphtheria Tetanus Pertussis Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diphtheria Tetanus Pertussis Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales, (K Units), 2024-2029
Table 46. Sanofi Pasteur Company Summary
Table 47. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 48. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Pasteur Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 52. GSK Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. AJ Vaccines Company Summary
Table 55. AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 56. AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AJ Vaccines Key News & Latest Developments
Table 58. KM Biologics (Meiji) Company Summary
Table 59. KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 60. KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. KM Biologics (Meiji) Key News & Latest Developments
Table 62. MCM Vaccine Company Summary
Table 63. MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 64. MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. MCM Vaccine Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 68. Merck Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Merck Key News & Latest Developments
Table 70. MassBiologics Company Summary
Table 71. MassBiologics Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 72. MassBiologics Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. MassBiologics Key News & Latest Developments
Table 74. Bionet-Asia Company Summary
Table 75. Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 76. Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Bionet-Asia Key News & Latest Developments
Table 78. Amson Vaccines & Pharma Company Summary
Table 79. Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 80. Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Amson Vaccines & Pharma Key News & Latest Developments
Table 82. Serum Institute of India Company Summary
Table 83. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 84. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Serum Institute of India Key News & Latest Developments
Table 86. Panacea Biotec Company Summary
Table 87. Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 88. Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Panacea Biotec Key News & Latest Developments
Table 90. BioKangtai Company Summary
Table 91. BioKangtai Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 92. BioKangtai Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. BioKangtai Key News & Latest Developments
Table 94. China National Biotec Company Summary
Table 95. China National Biotec Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 96. China National Biotec Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. China National Biotec Key News & Latest Developments
Table 98. Chengdu Oulin Biological Science&Technology Company Summary
Table 99. Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Product Offerings
Table 100. Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Chengdu Oulin Biological Science&Technology Key News & Latest Developments
Table 102. Diphtheria Tetanus Pertussis Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Diphtheria Tetanus Pertussis Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Diphtheria Tetanus Pertussis Vaccine Production by Region, 2018-2023 (K Units)
Table 105. Global Diphtheria Tetanus Pertussis Vaccine Production by Region, 2024-2029 (K Units)
Table 106. Diphtheria Tetanus Pertussis Vaccine Market Opportunities & Trends in Global Market
Table 107. Diphtheria Tetanus Pertussis Vaccine Market Drivers in Global Market
Table 108. Diphtheria Tetanus Pertussis Vaccine Market Restraints in Global Market
Table 109. Diphtheria Tetanus Pertussis Vaccine Raw Materials
Table 110. Diphtheria Tetanus Pertussis Vaccine Raw Materials Suppliers in Global Market
Table 111. Typical Diphtheria Tetanus Pertussis Vaccine Downstream
Table 112. Diphtheria Tetanus Pertussis Vaccine Downstream Clients in Global Market
Table 113. Diphtheria Tetanus Pertussis Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Diphtheria Tetanus Pertussis Vaccine Segment by Type in 2022
Figure 2. Diphtheria Tetanus Pertussis Vaccine Segment by Application in 2022
Figure 3. Global Diphtheria Tetanus Pertussis Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diphtheria Tetanus Pertussis Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diphtheria Tetanus Pertussis Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Diphtheria Tetanus Pertussis Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Diphtheria Tetanus Pertussis Vaccine Revenue in 2022
Figure 9. By Type - Global Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Diphtheria Tetanus Pertussis Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Diphtheria Tetanus Pertussis Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
Figure 23. US Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
Figure 37. China Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Diphtheria Tetanus Pertussis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Diphtheria Tetanus Pertussis Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Diphtheria Tetanus Pertussis Vaccine by Region, 2022 VS 2029
Figure 54. Diphtheria Tetanus Pertussis Vaccine Industry Value Chain
Figure 55. Marketing Channels

★調査レポート[世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場予測2023-2029：DTwP型、DTaP型] (コード：MMG23LY8469)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場予測2023-2029：DTwP型、DTaP型]についてメールでお問い合わせ

MarketReport.jp

世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場予測2023-2029：DTwP型、DTaP型

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp